Walid Chayoua
Overview
Explore the profile of Walid Chayoua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chayoua W, Visser K, de Koning M, Beishuizen A, IJmker R, van der Naalt J, et al.
J Neurotrauma
. 2024 Feb;
41(13-14):e1630-e1640.
PMID: 38326742
Mild traumatic brain injury (mTBI) is a common condition seen in emergency departments worldwide. Blood-based biomarkers glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase-L1 (UCH-L1) are recently U.S. Food...
2.
Vandevelde A, Chayoua W, de Laat B, Moore G, Musial J, Zuily S, et al.
J Thromb Haemost
. 2022 Jun;
20(9):2136-2150.
PMID: 35713971
Background: Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti-β2 glycoprotein I (aβ2GPI) IgG/IgM antibodies. Other antiphospholipid antibodies (aPL) such as antiphosphatidylserine/prothrombin...
3.
Vandevelde A, Chayoua W, de Laat B, Gris J, Moore G, Musial J, et al.
J Thromb Haemost
. 2021 Nov;
20(2):508-524.
PMID: 34758192
Background: Antiβ2glycoprotein I (aβ2GPI) and anticardiolipin (aCL) IgG/IgM show differences in positive/negative agreement and titers between solid phase platforms. Method-specific semiquantitative categorization of titers could improve and harmonize the interpretation...
4.
de Laat-Kremers R, Wahl D, Zuily S, Ninivaggi M, Chayoua W, Regnault V, et al.
Thromb Res
. 2021 May;
203:142-151.
PMID: 34022673
The antiphospholipid syndrome (APS) is diagnosed by the presence of lupus anticoagulant and/or antibodies against cardiolipin or β-glycoprotein-1 and the occurrence of thrombosis or pregnancy morbidity. The assessment of overall...
5.
Huang S, Ninivaggi M, Chayoua W, de Laat B
Int J Mol Sci
. 2021 Apr;
22(8).
PMID: 33919627
The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with the persistent presence of antiphospholipid antibodies (aPLs). Laboratory criteria for the classification of APS include the detection of...
6.
Chayoua W, Nicolson P, Meijers J, Kardeby C, Garcia-Quintanilla L, Devreese K, et al.
J Thromb Haemost
. 2021 Mar;
19(7):1776-1782.
PMID: 33774918
Background: Arterial and venous thrombosis are both common in antiphospholipid syndrome (APS). Recent studies have shown that anti-factor Xa (FXa) therapy in APS patients leads to a greater number of...
7.
Chayoua W, Yin D, Kelchtermans H, Moore G, Gris J, Musial J, et al.
Thromb Haemost
. 2020 Jul;
120(11):1557-1568.
PMID: 32696448
Background: Anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2GPI) immunoglobulin A (IgA) antiphospholipid antibodies (aPL) have shown to associate with thrombosis and pregnancy morbidity. However, inclusion of IgA aPL in the...
8.
Yin D, Chayoua W, Kelchtermans H, de Groot P, Moore G, Gris J, et al.
J Thromb Haemost
. 2019 Nov;
18(2):463-478.
PMID: 31749277
Background: Classification of the antiphospholipid syndrome (APS) relies predominantly on detecting antiphospholipid antibodies (aPLs). Antibodies against a domain I (DI) epitope of anti-β2glycoprotein I (β2GPI) proved to be pathogenic, but...
9.
Chayoua W, Kelchtermans H, Gris J, Moore G, Musial J, Wahl D, et al.
J Thromb Haemost
. 2019 Sep;
18(1):169-179.
PMID: 31519058
Background: The antiphospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with the persistent presence of lupus anticoagulant (LAC), anti-cardiolipin (aCL) and/or anti-β2glycoprotein I (aβ2GPI) antibodies of the immunoglobulin...
10.
Chayoua W, Kelchtermans H, Moore G, Gris J, Musial J, Wahl D, et al.
Thromb Haemost
. 2019 Mar;
119(5):797-806.
PMID: 30822809
Background: The anti-phospholipid syndrome (APS) is characterized by thrombosis and/or pregnancy morbidity with persistent presence of anti-phospholipid antibodies (aPL). Laboratory criteria include aPL detection by coagulation tests for lupus anticoagulant...